This lecture series highlights advocacy and policy experts who provide technical assistance and leadership development for physicians, residents, and medical students interested in conflict-of-interest reform efforts.
This lecture was recorded on May 29, 2014.
Call Recording – click here to listen or download (1:00:22)
Call Notes and Slide Presentation

Working to Reduce Conflict of Interest at the FDA 

Featured Speaker:

John H. Powers, MD FACP FIDSA
Associate Clinical Professor of Medicine
George Washington University School of Medicine
University of Maryland School of Medicine

Dr. Powers is a member of NPA’s FDA Task Force which was established to educate and empower a multispecialty group of NPA members, free of conflict-of-interest, to provide unbiased expertise in evaluating and responding to the FDA regulatory process in a way that maximizes meaningful clinical outcomes for our patients.

The NPA Task Force is working to insure that drug, biologic and medical device regulation is based in transparency, integrity and accountability, and firmly grounded in scientific evidence driven by public health interests.

Dr. Powers will discuss the work of the Task Force, including current efforts related to conflicts of interest and antibiotics.  

About our speaker:

John Powers, MD is Associate Clinical Professor of Medicine at the George Washington University School of Medicine.  Prior to his current position, John was the Lead Medical Officer for Antimicrobial Drug Development and Resistance Initiatives in the Office of Antimicrobial Products, Center for Drug Evaluation and Research, at the US Food and Drug Administration where he was responsible for issues related to clinical trials and policy in antimicrobial research. Prior to joining the FDA, John was assistant professor in the Division of Infectious Diseases at the University of Maryland School of Medicine and he still is on the faculty there as an Assistant Clinical Professor of Medicine. John also actively sees patients weekly in clinic and attends on the infectious diseases service.


Following the presentation we were joined by Reshma Ramachandran, MD, MPP Candidate, Brown Medical School/Harvard Kennedy School, American Medical Student Association Pharm-free Chair, and NPA FDA Task Force Member, for a discussion designed to help to answer questions and connect participants with project resources and new tools available to help reduce conflicts of interest at academic medical centers and in the medical profession.


This event is offered as part of the Partnership to Advance Conflict-free Medical Education(PACME). This partnership and related materials were made possible by a grant from the state Attorney General Consumer and Prescriber Education Grant Program which is funded by the multi-state settlement of consumer fraud claims regarding the
marketing of the prescription drug Neurontin.

The Partnership to Advance Conflict‐free Medical Education (PACME) is a joint project of the National Physicians Alliance,  the American Medical Student AssociationCommunity Catalyst, and the Pew Charitable Trusts designed to create both external and internal pressure for medical schools and academic medical centers to adopt strong new conflict-of-interest policies.

Learn more at